These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12411456)

  • 1. Treatment and control of hypertension in the community: a prospective analysis.
    Lloyd-Jones DM; Evans JC; Larson MG; Levy D
    Hypertension; 2002 Nov; 40(5):640-6. PubMed ID: 12411456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community.
    Lloyd-Jones DM; Evans JC; Larson MG; O'Donnell CJ; Roccella EJ; Levy D
    Hypertension; 2000 Oct; 36(4):594-9. PubMed ID: 11040241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension in adults across the age spectrum: current outcomes and control in the community.
    Lloyd-Jones DM; Evans JC; Levy D
    JAMA; 2005 Jul; 294(4):466-72. PubMed ID: 16046653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal change in left ventricular hypertrophy in the elderly on antihypertensive therapy.
    Ahmad A; Nawaz HM; Nevins L; Nawaz H
    Conn Med; 2003 Feb; 67(2):67-73. PubMed ID: 12664833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual Cardiovascular Risk in Individuals on Blood Pressure-Lowering Treatment.
    Lieb W; Enserro DM; Sullivan LM; Vasan RS
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26588944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of phenotypes at risk of transition from diastolic hypertension to isolated systolic hypertension.
    Esposito R; Izzo R; Galderisi M; De Marco M; Stabile E; Esposito G; Trimarco V; Rozza F; De Luca N; de Simone G
    J Hum Hypertens; 2016 Jun; 30(6):392-6. PubMed ID: 26355832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.
    Verdecchia P; Staessen JA; Angeli F; de Simone G; Achilli A; Ganau A; Mureddu G; Pede S; Maggioni AP; Lucci D; Reboldi G;
    Lancet; 2009 Aug; 374(9689):525-33. PubMed ID: 19683638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network).
    Lønnebakken MT; Izzo R; Mancusi C; Gerdts E; Losi MA; Canciello G; Giugliano G; De Luca N; Trimarco B; de Simone G
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac and vascular remodeling in older adults with borderline isolated systolic hypertension: the ICARe Dicomano Study.
    Pini R; Cavallini MC; Bencini F; Staglianò L; Tonon E; Innocenti F; Baldereschi G; Marchionni N; Di Bari M; Devereux RB; Masotti G; Roman MJ
    Hypertension; 2001 Dec; 38(6):1372-6. PubMed ID: 11751720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study.
    Larstorp AC; Ariansen I; Gjesdal K; Olsen MH; Ibsen H; Devereux RB; Okin PM; Dahlöf B; Kjeldsen SE; Wachtell K
    Hypertension; 2012 Aug; 60(2):347-53. PubMed ID: 22753219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive treatment is not a risk factor for major cardiovascular events in the Gubbio residential cohort study.
    Lanti M; Puddu PE; Vagnarelli OT; Laurenzi M; Cirillo M; Mancini M; Zanchetti A; Menotti A
    J Hypertens; 2015 Apr; 33(4):736-44; discussion 744. PubMed ID: 25915878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.
    Mosterd A; D'Agostino RB; Silbershatz H; Sytkowski PA; Kannel WB; Grobbee DE; Levy D
    N Engl J Med; 1999 Apr; 340(16):1221-7. PubMed ID: 10210704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study.
    Okin PM; Devereux RB; Harris KE; Jern S; Kjeldsen SE; Lindholm LH; Dahlöf B;
    Hypertension; 2007 Nov; 50(5):984-90. PubMed ID: 17893425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa.
    Brennan AT; Jamieson L; Crowther NJ; Fox MP; George JA; Berry KM; Stokes A; Maskew M; Sanne I; Long L; Cassim N; Rosen S
    PLoS One; 2018; 13(10):e0204020. PubMed ID: 30281618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular diastolic dyssynchrony in patients with treatment-naive hypertension and the effects of antihypertensive therapy.
    Kwon BJ; Lee SH; Park CS; Kim DB; Park HJ; Jang SW; Ihm SH; Youn HJ; Seung KB; Kim HY
    J Hypertens; 2015 Feb; 33(2):354-65. PubMed ID: 25333681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Antihypertensive Treatment Restore the Risk of Cardiovascular Disease to Ideal Levels?: The Coronary Artery Risk Development in Young Adults (CARDIA) Study and the Multi-Ethnic Study of Atherosclerosis (MESA).
    Liu K; Colangelo LA; Daviglus ML; Goff DC; Pletcher M; Schreiner PJ; Sibley CT; Burke GL; Post WS; Michos ED; Lloyd-Jones DM
    J Am Heart Assoc; 2015 Sep; 4(9):e002275. PubMed ID: 26391135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure as a cardiovascular risk factor: prevention and treatment.
    Kannel WB
    JAMA; 1996 May 22-29; 275(20):1571-6. PubMed ID: 8622248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypertension in renal failure patients: when do we overtreat? When do we undertreat?
    Rosansky SJ
    Blood Purif; 1996; 14(4):315-20. PubMed ID: 8873957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative.
    Wassertheil-Smoller S; Anderson G; Psaty BM; Black HR; Manson J; Wong N; Francis J; Grimm R; Kotchen T; Langer R; Lasser N
    Hypertension; 2000 Nov; 36(5):780-9. PubMed ID: 11082143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of left ventricular structure on the incidence of hypertension. The Framingham Heart Study.
    Post WS; Larson MG; Levy D
    Circulation; 1994 Jul; 90(1):179-85. PubMed ID: 8025994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.